depression
How Many People Are Eligible for Psilocybin-Assisted Therapy?
Study: Psilocybin Boosts Optimism
NRx Pharmaceuticals Completes 12 Months of Stability on First Commercial-Scale Lot of IV Ketamine
Study: Millions Could Benefit From Psilocybin-Assisted Therapy
Johnson & Johnson Seeks FDA Approval of Spravato as Monotherapy for Adults with Treatment-Resistant Depression
1 2